Want China Times
A research team from National Taiwan University (NTU) has succeeded in identifying a
genome mutation highly correlated with lung cancer using rapid whole-genome sequencing technology, and the discovery can improve the diagnosis of early-stage lung cancer.
At a press briefing Thursday, researchers said that lung cancer remained the No. 1 killer among all diseases in Taiwan. Most lung cancers are first diagnosed based on symptoms, but symptoms of early-stage lung cancer are not very specific, thus causing difficulties in screening.
At the moment, the only method to identify groups with a high risk of developing lung cancer is resorting to familial penetrance.
In order to identify the risk factors, the research team conducted a study of a family with an atypically high density of lung cancer. By analyzing the data collected in the process of conducting rapid whole-genome sequencing of family members, the researchers succeeded in identifying a key genome mutation. [FULL STORY]